Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.01 | 1 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |